NEW YORK, NY / ACCESSWIRE / October 30, 2022 / Why: Rosen Law Firm, a global investor rights law firm, is recalling the buyer of the securities of Fulgent Genetics, Inc. (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, both dates inclusive (the “Separation Period”), important November 21, 2022 Deadline for Lead Plaintiff.
so what: If you purchase Fulgent Genetics securities during the term, you may be entitled to compensation without paying any fees or out-of-pocket costs through a contingency fee arrangement.
What to do next: To join the work of the Fulgent Genetics class, go to https://rosenlegal.com/submit-form/?case_id=8809 Or contact Phillip Kim, Esq. Toll-free at 866-767-3653 or email [email protected] or [email protected] For information about the class action. A class action lawsuit has already been filed. If you want to act as lead plaintiff, you must move court No later than November 21, 2022. The lead plaintiff is a representative party acting on behalf of other class members in directing litigation.
Why Rosen Low: Investors are encouraged to select a qualified advisor with a proven track record of success in leadership roles. Often, the companies issuing the notifications do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually handle securities class litigations, but are merely intermediaries who refer clients or associate with law firms that are actually suing the issues. Be wise in choosing a lawyer. Rosen Law Firm represents investors worldwide, focusing its practice in securities class litigation and shareholder derivative litigation. Rosen Law Firm has achieved the largest-ever securities class action settlement against a Chinese company. Rosen Law Firm has been ranked No. 1 by ISS Securities Class Action Services in the number of securities class claims settlements in 2017. The firm has been ranked No. 4 every year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone, the company raised more than $438 million for investors. In 2020, co-founder Laurence Rosen was named under Act 360 as the Titan of Plaintiffs’ Bar. Several of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Case details: According to the lawsuit, throughout the course of the lawsuit, Defendants have made false and/or misleading statements and/or failed to disclose the following: (i) Fulgent Genetics has been conducting medically unnecessary lab tests, engaging in improper billing practices in connection with relating to laboratory testing, and offering or receiving remuneration in violation of the Anti-bribery Act (which prohibits the knowing and willful payment of a “reward” to induce or reward patient referrals or create business involving any item or service payable by federal healthcare programs) and the Stark Act Federal (which prohibits a physician from making referrals of certain certain health services, including laboratory services, covered by Medicare, to an entity with which the physician or an immediate family member has a direct or indirect financial relationship); (ii) Accordingly, Fulgent Genetics is likely to be subject to further legal and regulatory scrutiny; (3) the proceeds of Fulgent Genetics were, to the extent obtained from prior illegal conduct, unsustainable; (iv) the foregoing, once disclosed, is likely to expose Fulgent Genetics to significant financial and/or reputational damage; and (5) as a result, the defendants’ public statements were materially false and misleading at all relevant times. When the real details entered the market, the lawsuit alleges that investors were harmed.
To join the work of the Fulgent Genetics class, go to https://rosenlegal.com/submit-form/?case_id=8809 Or contact Phillip Kim, Esq. Toll-free at 866-767-3653 or email [email protected] or [email protected] For information about the class action.
No category is supported. Until the semester is approved, you are not represented by an attorney unless you keep one. You can choose a lawyer of your choice. You can also remain an absent class member and do nothing at this point. An investor’s ability to participate in any possible future redemption is not dependent on acting as lead claimant.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firmon Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Advertisement attorney. Previous results do not guarantee similar results.
Lawrence Rosen, Esq.
Philip Kim, Esq.
Rosen Law Firm, Pennsylvania
275 Madison Street, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
source: Rosen Law Firm PA
View the source version on accesswire.com: